Sibopirdine
Sibopirdine, also known as EXP921, is a nootropic drug.[1]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H18N4 |
Molar mass | 350.425 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Synthesis
![](../I/m/Sibopirdine_synthesis.png)
Sibopirdine synthesis: DuPont Merck Pharmaceutical Company; U.S. Patent 5,272,269 (1993).
4,5-Diazafluoren-9-one was the starting material.
gollark: `units` is pretty great for simple stuff.
gollark: osmarkscalculator™, inevitably?
gollark: They are sold to, effectively, the education sector, which wants constrained computers.
gollark: Calculators aren't really sold to people who actually need good general purpose... calculators... because computers are too good now.
gollark: Implement Turi, the best esolang.
See also
References
- Wong YN, Quon CY, Holm KA, Burcham DL, Frey NL, Huang SM, Lam GN (February 1996). "Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats". Drug Metabolism and Disposition. 24 (2): 172–9. PMID 8742228.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.